BGB-DXP604
N/A
Report date: 2026/05/21 20:00:22
Base Information
Drug NameBGB-DXP604
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSinglomics Biopharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeOne Medicines LtdSinglomics Biopharmaceuticals Co Ltd
Inactive CompaniesWuhan Institute Of Biological Products Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A